1.
N Engl J Med
; 367(9): 851-61, 2012 Aug 30.
Article
in English
| MEDLINE
| ID: mdl-22931320
Subject(s)
Breast Neoplasms/pathology , Carcinoma, Ductal, Breast/pathology , Limbic Encephalitis/etiology , Lymph Nodes/pathology , Stiff-Person Syndrome/etiology , Antibodies/blood , Back Pain/etiology , Brain/pathology , Breast Neoplasms/complications , Breast Neoplasms/surgery , Carcinoma, Ductal, Breast/complications , Carcinoma, Ductal, Breast/surgery , Diagnosis, Differential , Female , Humans , Limbic Encephalitis/diagnosis , Lymphatic Metastasis , Magnetic Resonance Imaging , Memory Disorders/etiology , Middle Aged , Neoplasms, Unknown Primary , Nerve Tissue Proteins/immunology , Reflex, Abnormal , Spasm/etiology , Stiff-Person Syndrome/diagnosis
2.
J Natl Compr Canc Netw
; 10(7): 821-9, 2012 Jul 01.
Article
in English
| MEDLINE
| ID: mdl-22773798
ABSTRACT
These NCCN Guidelines Insights highlight the important updates/changes specific to the management of metastatic breast cancer in the 2012 version of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Breast Cancer. These changes/updates include the issue of retesting of biomarkers (estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2) on recurrent disease, new information regarding first-line combination endocrine therapy for metastatic disease, a new section on monitoring of patients with metastatic disease, and new information on endocrine therapy combined with an mTOR inhibitor as a subsequent therapeutic option.
